IR BIOTECH
TOULOUSE / 15 chemin de la crabe
|
A new international player in immuno-oncology and immuno-virology, our ambition is to be an innovative and active company in research in immunology (immunotherapy, vaccine therapy and immunological diagnosis) and in oncology (immunostimulation of TCD8 populations, immuno -modulation…). We plan to develop new antiviral and anti-cancer vaccine strategies as well as diagnostic tests favoring cell-mediated immunity |
|||||||||
| Business axis : |
Diagnostic Others
|
||||||||
| Category : | TPE | ||||||||
| Legal form : | SASU | ||||||||
| Website : | |||||||||